Squarepoint Ops LLC Dexcom Inc Transaction History

Squarepoint Ops LLC

$62.8 Billion
Q3 2024

A detailed history of Squarepoint Ops LLC transactions in Dexcom Inc stock. As of the latest transaction made, Squarepoint Ops LLC holds 739,971 shares of DXCM stock, worth $58.9 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

739,971

Previous 341,951 116.4%

Holding current value

$58.9 Million

Previous $38.8 Million 27.91%

% of portfolio

0.08%

Previous 0.07%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$64.0 - $116.06 $25.5 Million - $46.2 Million	398,020 Added 116.4%	739,971 $49.6 Million
Q2 2024 Aug 14, 2024	BUY	$110.31 - $140.45 $23.9 Million - $30.4 Million	216,282 Added 172.1%	341,951 $38.8 Million
Q1 2024 May 15, 2024	BUY	$114.22 - $140.1 $2.54 Million - $3.11 Million	22,218 Added 21.48%	125,669 $17.4 Million
Q4 2023 Feb 14, 2024	SELL	$75.49 - $124.16 $33.3 Million - $54.8 Million	-441,161 Reduced 81.0%	103,451 $12.8 Million
Q2 2023 Aug 14, 2023	BUY	$112.47 - $130.98 $29.3 Million - $34.1 Million	260,196 Added 91.48%	544,612 $70 Million
Q1 2023 May 15, 2023	BUY	$104.0 - $122.92 $24.3 Million - $28.7 Million	233,622 Added 459.94%	284,416 $33 Million
Q4 2022 Feb 14, 2023	SELL	$84.98 - $122.67 $33.8 Million - $48.9 Million	-398,291 Reduced 88.69%	50,794 $5.75 Million
Q3 2022 Nov 14, 2022	BUY	$76.35 - $94.18 $8.34 Million - $10.3 Million	109,236 Added 32.14%	449,085 $36.2 Million
Q2 2022 Aug 15, 2022	BUY	$67.99 - $132.89 $22 Million - $43.1 Million	324,122 Added 2060.93%	339,849 $25.3 Million
Q1 2022 May 16, 2022	SELL	$94.08 - $130.2 $5.36 Million - $7.42 Million	-56,977 Reduced 78.37%	15,727 $8.05 Million
Q4 2021 Feb 14, 2022	BUY	$129.87 - $162.82 $9.2 Million - $11.5 Million	70,817 Added 3752.89%	72,704 $39 Million
Q3 2021 Nov 15, 2021	SELL	$106.71 - $143.18 $255,357 - $342,629	-2,393 Reduced 55.91%	1,887 $1.03 Million
Q2 2021 Aug 16, 2021	SELL	$80.99 - $107.93 $2.73 Million - $3.63 Million	-33,672 Reduced 88.72%	4,280 $1.83 Million
Q1 2021 May 17, 2021	BUY	$84.79 - $104.74 $3.01 Million - $3.71 Million	35,442 Added 1412.03%	37,952 $13.6 Million
Q4 2020 Feb 16, 2021	SELL	$78.0 - $104.5 $38,220 - $51,205	-490 Reduced 16.33%	2,510 $928,000
Q3 2020 Nov 16, 2020	SELL	$95.51 - $112.95 $602,954 - $713,053	-6,313 Reduced 67.79%	3,000 $1.24 Million
Q2 2020 Aug 14, 2020	SELL	$62.68 - $105.34 $734,045 - $1.23 Million	-11,711 Reduced 55.7%	9,313 $3.78 Million
Q1 2020 May 15, 2020	SELL	$47.79 - $75.63 $763,493 - $1.21 Million	-15,976 Reduced 43.18%	21,024 $5.66 Million
Q4 2019 Feb 14, 2020	BUY	$36.62 - $57.29 $1.35 Million - $2.12 Million	37,000 New	37,000 $8.09 Million
Q3 2019 Nov 14, 2019	SELL	$35.53 - $43.8 $2.45 Million - $3.02 Million	-69,014 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$27.84 - $38.92 $1.92 Million - $2.69 Million	69,014 New	69,014 $10.3 Million
Q1 2019 May 15, 2019	SELL	$28.07 - $38.18 $3.69 Million - $5.02 Million	-131,590 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$26.99 - $37.37 $1.66 Million - $2.3 Million	61,583 Added 87.97%	131,590 $15.8 Million
Q3 2018 Nov 14, 2018	SELL	$23.35 - $36.72 $2.9 Million - $4.56 Million	-124,057 Reduced 63.93%	70,007 $10 Million
Q2 2018 Aug 14, 2018	BUY	$17.54 - $25.22 $3.4 Million - $4.89 Million	194,064 New	194,064 $18.4 Million
Q1 2018 May 15, 2018	SELL	$13.06 - $18.54 $1.59 Million - $2.26 Million	-122,087 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$11.12 - $15.38 $1.28 Million - $1.76 Million	114,724 Added 1558.11%	122,087 $7.01 Million
Q3 2017 Nov 14, 2017	BUY	$11.36 - $18.98 $83,643 - $139,749	7,363	7,363 $360,000

Others Institutions Holding DXCM

# of Institutions

1,014

Shares Held

351M

Call Options Held

5.51M

Put Options Held

5.6M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $30.7B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Account

Squarepoint Ops LLC Dexcom Inc Transaction History